| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Accelerated Approval or Risk Reduction? How Response Biomarkers Advance Therapeutics through Clinical Trials in Cystic Fibrosis
|
Mayer-Hamblett, N.
|
|
|
26 |
12 |
p. 1068-1077
|
article
|
| 2 |
A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes
|
Cabler, Stephanie S.
|
|
|
26 |
12 |
p. 1078-1085
|
article
|
| 3 |
Advisory Board and Contents
|
|
|
|
26 |
12 |
p. i-ii
|
article
|
| 4 |
Blocking CTGF-Mediated Tumor–Stroma Interplay in Pancreatic Cancer
|
Shen, Yi-Wen
|
|
|
26 |
12 |
p. 1064-1067
|
article
|
| 5 |
Differential Markers of Bacterial and Viral Infections in Children for Point-of-Care Testing
|
Tsao, Yu-Ting
|
|
|
26 |
12 |
p. 1118-1132
|
article
|
| 6 |
Fibroblast Heterogeneity in Wound Healing: Hurdles to Clinical Translation
|
Mascharak, Shamik
|
|
|
26 |
12 |
p. 1101-1106
|
article
|
| 7 |
HDL and Reverse Remnant-Cholesterol Transport (RRT): Relevance to Cardiovascular Disease
|
Kontush, Anatol
|
|
|
26 |
12 |
p. 1086-1100
|
article
|
| 8 |
RNA Therapeutics Are Stepping Out of the Maze
|
Agrawal, Sudhir
|
|
|
26 |
12 |
p. 1061-1064
|
article
|
| 9 |
Subscr+copyr
|
|
|
|
26 |
12 |
p. e1
|
article
|
| 10 |
The Ubiquitin/UBL Drug Target Repertoire
|
Osborne, Hugh C.
|
|
|
26 |
12 |
p. 1133-1134
|
article
|
| 11 |
Wound Repair, Scar Formation, and Cancer: Converging on Activin
|
Cangkrama, Michael
|
|
|
26 |
12 |
p. 1107-1117
|
article
|
Journal description